These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3327168)

  • 21. Systemic lupus erythematosus. Some contemporary laboratory aspects.
    Deegan MJ
    Arch Pathol Lab Med; 1980 Aug; 104(8):399-404. PubMed ID: 6967303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of antinuclear factors and immunoglobulins bound to the dermo-epidermal junction in patients with chronic biological false positive (CBFP) reactions for syphilis.
    Johansson EA; Lassus A; Salo OP
    Acta Derm Venereol; 1972; 52(3):196-200. PubMed ID: 4115440
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical significance of the lupus band test in systemic lupus erythematosus (author's transl)].
    Yasue T
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):901-7. PubMed ID: 7012400
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 26. [Direct immunofluorescence in cutaneous lupus erythematosus].
    Honeyman Mauro JF; Robles Velasco A
    Med Cutan Ibero Lat Am; 1976; 4(1):41-4. PubMed ID: 790052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of immunofluorescence methods in dermatology (technic and clinical use)].
    Barthelmes H; Sönnichsen N
    Dermatol Monatsschr; 1970; 156(3):184-211. PubMed ID: 4934301
    [No Abstract]   [Full Text] [Related]  

  • 28. Lupus nephritis: immunofluorescence study of 54 cases.
    Morel-Maroger L; Méry JP; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1183-6. PubMed ID: 4610502
    [No Abstract]   [Full Text] [Related]  

  • 29. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 30. The gammaG subclass of antinuclear and antinucleic acid antibodies.
    Schur PH; Monroe M; Rothfield N
    Arthritis Rheum; 1972; 15(2):174-82. PubMed ID: 4554890
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    Gilliam JN; Cheatum DE; Hurd ER; Stastny P; Ziff M
    J Clin Invest; 1974 May; 53(5):1434-40. PubMed ID: 4596508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
    Andres GA; Accinni L; Beiser SM; Christian CL; Cinotti GA; Erlanger BF; Hsu KC; Seegal BC
    J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct immunofluorescence of bullous systemic lupus erythematosus.
    Pedro SD; Dahl MV
    Arch Dermatol; 1973 Jan; 107(1):118-20. PubMed ID: 4566188
    [No Abstract]   [Full Text] [Related]  

  • 34. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
    Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients.
    Hashimoto H; Tsuda H; Takasaki Y; Fujimaki N; Suzuki M; Shiokawa Y
    J Rheumatol; 1983 Oct; 10(5):727-32. PubMed ID: 6606040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunofluorescence skin test for lupus erythematosus. A correlative study between frequency and patterns of skin test results, glomerular pathologic abnormalities, and immunologic findings.
    Boonpucknavig V; Boonpucknavig S; Vuttivirojana O; Yaemboonruang CC
    Arch Pathol Lab Med; 1977 Jul; 101(7):350-3. PubMed ID: 326224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunofluorescent "band" test for lupus erythematosus. I. Morphologic variations of the band of localized immunoglobulins at the dermal-epidermal junction in lupus erythematosus.
    Burnham TK; Fine G
    Arch Dermatol; 1969 Apr; 99(4):413-20. PubMed ID: 4181409
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunofluorescence study of cutaneous blood vessels of 16 patients with systemic lupus erythematosus.
    Igarashi R; Morohashi M; Koizumi F; Nitto H; Inomata N; Sato Y
    Acta Derm Venereol; 1981; 61(3):219-23. PubMed ID: 6167104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunomorphological changes in the skin of patients with systemic lupus erythematosus and the effect of cytostatic therapy].
    Solov'ev SK; Akhnazarova VD; Ivanova MM
    Ter Arkh; 1981; 53(7):33-6. PubMed ID: 7027510
    [No Abstract]   [Full Text] [Related]  

  • 40. [The lupus band test. IV. Findings in persistent ANA negative SLE].
    Wollina U; Tanner E; Knopf B
    Dermatol Monatsschr; 1986; 172(11):664-8. PubMed ID: 3545925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.